Carisma Therapeutics, Inc.
CARM
$0.2118
-$0.0017-0.80%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/30/2025
-
Ticker Report
4/23/2025
-
Ticker Report
4/2/2025
-
Simply Wall St
4/1/2025
-
FierceBiotech.com - Biotech
4/1/2025
-
Bizjournals.com - Health Care News
3/31/2025
-
GuruFocus
3/31/2025
-
PR Newswire
3/28/2025
-
Simply Wall St
3/26/2025
-
Business Wire
2/19/2025
-
GuruFocus
2/19/2025
-
PR Newswire
2/5/2025
-
GuruFocus
2/5/2025
-
PR Newswire
2/3/2025
-
Ticker Report
1/9/2025
-
Ticker Report
1/3/2025
-
Ticker Report
12/26/2024
-
TipRanks Financial Blog
12/17/2024
-
Ticker Report
12/16/2024
-
The Fly
12/12/2024
-
TipRanks Financial Blog
12/12/2024
-
TipRanks Financial Blog
12/12/2024
-
The Fly
12/12/2024
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 31, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
267 491 6422
Address
3675 Market Street
Philadelphia, PA 19104
Philadelphia, PA 19104
Country
Year Founded
Business Description
Sector
Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidate includes...
more